About PolyNovo
PolyNovo is a company based in Port Melbourne (Australia) founded in 2004.. The company has 301 employees as of June 30, 2025. PolyNovo offers products and services including NovoSorb BTM and NovoSorb Technology. PolyNovo operates in a competitive market with competitors including Kerecis, Dimension Inx, Kitotech Medical, microMend and RevBio, among others.
- Headquarter Port Melbourne, Australia
- Employees 301 as on 30 Jun, 2025
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Polynovo Limited
-
Annual Revenue
$84.08 M (USD)23.31as on Jun 30, 2025
-
Net Profit
$8.73 M (USD)151.17as on Jun 30, 2025
-
EBITDA
$5.16 M (USD)100.31as on Jun 30, 2025
-
Latest Funding Round
$15 M (USD), Grant
Apr 28, 2024
-
Investors
Victorian Government
& 1 more
-
Employee Count
301
as on Jun 30, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PolyNovo
PolyNovo is a publicly listed company on the ASX with ticker symbol PNV in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PolyNovo
PolyNovo offers a comprehensive portfolio of products and services, including NovoSorb BTM and NovoSorb Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Biodegradable matrix for temporary skin coverage and healing.
Platform for developing synthetic skin substitutes.
Unlock access to complete
Software Development Team
41 people
Sales and Marketing
12 people
Area Team
9 people
Leadership Team
5 people
Product Management Team
5 people
Finance and Accounting
4 people
Human Resources and Administration
4 people
Medical Team
2 people
Unlock access to complete
Funding Insights of PolyNovo
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $15.0M
-
First Round
First Round
(14 Jul 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Grant - PolyNovo | Valuation |
investors |
|
| Jul, 2020 | Amount | Grant - PolyNovo | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PolyNovo
PolyNovo has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Victorian Government and Public Health Emergency. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Governance and public services for Victoria are administered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PolyNovo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PolyNovo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Polynovo Comparisons
Competitors of PolyNovo
PolyNovo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Dimension Inx, Kitotech Medical, microMend and RevBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| domain | founded_year | HQ Location |
3D biomaterials are provided for regenerative medicine applications.
|
|
| domain | founded_year | HQ Location |
Developer of a device to close wounds, lacerations, and surgical incisions
|
|
| domain | founded_year | HQ Location |
Solutions for treating dermatological disorders are provided by microMend.
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Polynovo
Frequently Asked Questions about PolyNovo
When was PolyNovo founded?
PolyNovo was founded in 2004 and raised its 1st funding round 16 years after it was founded.
Where is PolyNovo located?
PolyNovo is headquartered in Port Melbourne, Australia. It is registered at Port Melbourne, Victoria, Australia.
How many employees does PolyNovo have?
As of Jun 30, 2025, the latest employee count at PolyNovo is 301.
What is the annual revenue of PolyNovo?
Annual revenue of PolyNovo is $84.08M as on Jun 30, 2025.
What does PolyNovo do?
PolyNovo is a developer of biodegradable temporising matrix for treating traumatic wounds. It has developed a synthetic polymer that is a biodegradable product used to temporarily close the wound in generating new tissue. It has a NovoSorb matrix that allows for the infiltration of cellular materials and serves as a matrix to aid in the reconstruction of the deeper layers of the skin. The NovoSorb BTM can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.
Who are the top competitors of PolyNovo?
PolyNovo's top competitors include Kerecis, RevBio and Kitotech Medical.
What products or services does PolyNovo offer?
PolyNovo offers NovoSorb BTM and NovoSorb Technology.
Is PolyNovo publicly traded?
Yes, PolyNovo is publicly traded on ASX under the ticker symbol PNV.
Who are PolyNovo's investors?
PolyNovo has 2 investors. Key investors include Victorian Government, and Public Health Emergency.
What is PolyNovo's ticker symbol?
The ticker symbol of PolyNovo is PNV on ASX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.